Nucleic Acid Testing: Market Research Report
This report analyzes the Global market for Nucleic Acid Testing in US$ Million.
Annual estimates and forecasts are provided for the period 2006 through 2015.
The report profiles 46 companies including many key and niche players such as Abbott Laboratories, Inc., Agilent Life Sciences and Chemical Analysis, Applied Biosystems Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cepheid, Inc., Genomic Health, Inc., Gen-Probe Inc., Genzyme Corp., Genzyme Genetics, Myriad Genetics, Inc., Novartis AG, QIAGEN NV, Roche Diagnostics, Siemens Healthcare Diagnostics, Inc., and Third Wave Technologies, Inc.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select online sources.
Annual estimates and forecasts are provided for the period 2006 through 2015.
The report profiles 46 companies including many key and niche players such as Abbott Laboratories, Inc., Agilent Life Sciences and Chemical Analysis, Applied Biosystems Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cepheid, Inc., Genomic Health, Inc., Gen-Probe Inc., Genzyme Corp., Genzyme Genetics, Myriad Genetics, Inc., Novartis AG, QIAGEN NV, Roche Diagnostics, Siemens Healthcare Diagnostics, Inc., and Third Wave Technologies, Inc.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select online sources.
I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Nucleic Acid Test
Polymerase Chain Reaction or PCR Tests
Reverse Transcriptase PCR or RT-PCR Tests
Branched DNA or Quantiplex bDNA Tests
II. EXECUTIVE SUMMARY
1.MARKET OVERVIEW
Introduction
Current and Future Analysis
A Glance at the Nucleic Acid Testing Market
Point of Care (POC) Nucleic Acid Tests
Lateral Flow Platform-An Alternative to POC Nucleic Acid Testing
2.MARKET TRENDS
Veterinary Industry Eyes on Nucleic Acid Testing Kits and Immunodiagnostics
Home-Brewing Methods Continue to Dominate the NAPI Markets
Molecular Diagnostics – A Largely Untapped Market
Low-Priced Commercial Products to Mar the Popularity of Conventional Nucleic Acid Isolation Methods
Novel Applications and Technologies Widen Customer Base for Nucleic Acid Isolation Processes
FDA Licenses Nucleic Acid Tests Usage for Screening Hepatitis C and HIV
Usage of NAT for Screening Additional Categories of HIV in Tissues and Donated Blood Approved by FDA
3.PRODUCT OVERVIEW
What is a Nucleic Acid Test?
Polymerase Chain Reaction or PCR Tests
Reverse Transcriptase PCR or RT-PCR Tests
Branched DNA or Quantiplex bDNA Tests
Applications of NAT
NAT for Hepatitis C Virus Infection (HCV)
Qualitative Tests
Clinical Uses of Qualitative Nucleic Acid Test
Quantitative Tests
Real-Time PCR Method
Use of NAA for Diagnosing Tuberculosis
Factors Hindering the Adoptability of NAA Tests for Tuberculosis
Use of NAA for Diagnosing STI
Use of Nucleic Acid Sequence-Based Amplification for Diagnosing Dengue Viral RNA
Segments of NAT Technology
Amplified Probe Technology
Signal Amplification
Probe Amplification
Target Amplification
Direct Nucleic Acid Probes
Types of Techniques
In-situ hybridization (ISH)
Southern Blot
Liquid Hybridization
Working Procedure of Nucleic Acid Tests
Impediments for Using Technology
Capturing Methods for Discovering Nucleic Acid Lateral Flow (NALF)
Multiplex Nucleic Acid Testing
4.REGIONAL MARKET PERSPECTIVE
4A.THE UNITED STATES
A. MARKET ANALYSIS
Outlook
A Snapshot of the US Nucleic Acid Testing Market
Soaring Demand from Various Applications Drives the US NAPI Market
Use of NAT in STDs and HPV
B. MARKET ANALYTICS
4B.REST OF WORLD
A. MARKET ANALYSIS
Outlook
Overview of Select Regional Markets
Europe
A Glance at the Europe’s Nucleic Acid Testing and Blood Safety Market
China
Chinese Nucleic Acid Testing Market: An Overview
B. MARKET ANALYTICS
5.PRODUCT LAUNCHES
DaAn Gene Unveils Nucleic Acid Testing Kit for Influenza A H1N1 Virus
Sequenom Launches SensiGene Cystic Fibrosis Carrier Screening Test
Jeevan Introduces Nucleic Acid Testing
6.STRATEGIC CORPORATE DEVELOPMENTS
Gen-Probe Acquires Prodesse
STRATEC Takes Over Invitek
Becton, Dickinson and Company Takes Over Handy Lab
Gen-Probe Acquires Tepnel Life Sciences
Micronics and Biosearch Technologies Ink Licensing Agreement
Quidel and BioHelix Sign Agreement
BlueGnome Signs Agreement with Rubicon Genomics
DaAn Gene to Setup Four Joint Ventures
Gen-Probe and Chiron to Extend Partnership
EnviroLogix Inks Licensing Agreement with Ionian Technologies
HandyLab Extends Partnership with Epoch Biosciences
QIAGEN to Provide Molecular Testing Solutions to Bio-Manguinhos
Nanogen Signs Licensing and Supply Agreement with HandyLab
Blood System Laboratories and Florida Blood Services Establish a Joint Venture
Teva Collaborates with Compugen
QIAGEN Takes-Over Biotage’s Biosystems Unit
QIAGEN Snaps Up Corbett Life Science
Agilent Technologies to Expand API Manufacturing Plant
Polyclone Bioservices to Establish Nucleic Acid Testing Units in India
Pacgen Biopharmaceuticals Signs LoI with Medigen Biotechnology
easyDNA Establishes New DNA Testing Center in India
Apollo Chennai Establishes Nucleic Acid Testing Unit
7.OTHER DEVELOPMENTS
Nanosphere Receives FDA Approval for Respiratory Virus Assay
Roche Diagnostics Obtains FDA Approval for Broader Usage of Nucleic Acid Test
US and European Patent Authorities Award Patents to Gen-Probe for NAT
The National Institute of Allergy and Infectious Diseases Awards $770,000 to Micronics
DaAn Gene Obtains SFDA Approval for Marketing Nucleic Acid Test Kits
Luminex Molecular Diagnostics xTAG Respiratory Viral Panel Approved by FDA
Siemens Healthcare’s Apple iMac OSX Operating System Approved by FDA
Micronics Receives NIH Grant for Developing HIV POC Test
8.FOCUS ON SELECT PLAYERS
Abbott Laboratories, Inc. (US)
Agilent Life Sciences and Chemical Analysis (US)
Applied Biosystems Group (US)
Becton, Dickinson and Company (US)
Bio-Rad Laboratories, Inc. (US)
Cepheid, Inc. (US)
Genomic Health, Inc. (US)
Gen-Probe Inc. (US)
Genzyme Corp. (US)
Genzyme Genetics (US)
Myriad Genetics, Inc. (US)
Novartis AG (Switzerland)
QIAGEN NV (Netherlands)
Roche Diagnostics (US)
Siemens Healthcare Diagnostics, Inc. (US)
Third Wave Technologies, Inc. (US)
9.GLOBAL MARKET PERSPECTIVE
III. COMPETITIVE LANDSCAPE
Total Companies Profiled: 46 (including Divisions/Subsidiaries - 49)
Region/CountryPlayers
The United States
Canada
Europe
France
Germany
The United Kingdom
Rest of Europe
Asia-Pacific (Excluding Japan)
Latin America
Middle-East
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Nucleic Acid Test
Polymerase Chain Reaction or PCR Tests
Reverse Transcriptase PCR or RT-PCR Tests
Branched DNA or Quantiplex bDNA Tests
II. EXECUTIVE SUMMARY
1.MARKET OVERVIEW
Introduction
Current and Future Analysis
A Glance at the Nucleic Acid Testing Market
Point of Care (POC) Nucleic Acid Tests
Lateral Flow Platform-An Alternative to POC Nucleic Acid Testing
2.MARKET TRENDS
Veterinary Industry Eyes on Nucleic Acid Testing Kits and Immunodiagnostics
Home-Brewing Methods Continue to Dominate the NAPI Markets
Molecular Diagnostics – A Largely Untapped Market
Low-Priced Commercial Products to Mar the Popularity of Conventional Nucleic Acid Isolation Methods
Novel Applications and Technologies Widen Customer Base for Nucleic Acid Isolation Processes
FDA Licenses Nucleic Acid Tests Usage for Screening Hepatitis C and HIV
Usage of NAT for Screening Additional Categories of HIV in Tissues and Donated Blood Approved by FDA
3.PRODUCT OVERVIEW
What is a Nucleic Acid Test?
Polymerase Chain Reaction or PCR Tests
Reverse Transcriptase PCR or RT-PCR Tests
Branched DNA or Quantiplex bDNA Tests
Applications of NAT
NAT for Hepatitis C Virus Infection (HCV)
Qualitative Tests
Clinical Uses of Qualitative Nucleic Acid Test
Quantitative Tests
Real-Time PCR Method
Use of NAA for Diagnosing Tuberculosis
Factors Hindering the Adoptability of NAA Tests for Tuberculosis
Use of NAA for Diagnosing STI
Use of Nucleic Acid Sequence-Based Amplification for Diagnosing Dengue Viral RNA
Segments of NAT Technology
Amplified Probe Technology
Signal Amplification
Probe Amplification
Target Amplification
Direct Nucleic Acid Probes
Types of Techniques
In-situ hybridization (ISH)
Southern Blot
Liquid Hybridization
Working Procedure of Nucleic Acid Tests
Impediments for Using Technology
Capturing Methods for Discovering Nucleic Acid Lateral Flow (NALF)
Multiplex Nucleic Acid Testing
4.REGIONAL MARKET PERSPECTIVE
4A.THE UNITED STATES
A. MARKET ANALYSIS
Outlook
A Snapshot of the US Nucleic Acid Testing Market
Soaring Demand from Various Applications Drives the US NAPI Market
Use of NAT in STDs and HPV
B. MARKET ANALYTICS
Table 1. US Recent Past, Current & Future Analysis for Nucleic Acid Testing Markets with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
4B.REST OF WORLD
A. MARKET ANALYSIS
Outlook
Overview of Select Regional Markets
Europe
A Glance at the Europe’s Nucleic Acid Testing and Blood Safety Market
Table 2. European Recent Past, Current & Future Analysis for Nucleic Acid-based Amplification Reagents Markets by Geographic Region-France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 3. European 10-Year Perspective for Nucleic Acid–based Amplification Reagents by Geographic Region – Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain and Rest of Europe Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
Table 4. European Recent Past, Current & Future Analysis for Nucleic Acid-based Amplification Reagents by Segment- Genetic Testing, Infectious Diseases and Transplant Diagnostics Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 5. European 10-Year Perspective for Nucleic Acid–based Amplification Reagents by Segment - Percentage Breakdown of Revenues for Genetic Testing, Infectious Diseases and Transplant Diagnostics Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
China
Chinese Nucleic Acid Testing Market: An Overview
B. MARKET ANALYTICS
Table 6. Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Testing Markets with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
5.PRODUCT LAUNCHES
DaAn Gene Unveils Nucleic Acid Testing Kit for Influenza A H1N1 Virus
Sequenom Launches SensiGene Cystic Fibrosis Carrier Screening Test
Jeevan Introduces Nucleic Acid Testing
6.STRATEGIC CORPORATE DEVELOPMENTS
Gen-Probe Acquires Prodesse
STRATEC Takes Over Invitek
Becton, Dickinson and Company Takes Over Handy Lab
Gen-Probe Acquires Tepnel Life Sciences
Micronics and Biosearch Technologies Ink Licensing Agreement
Quidel and BioHelix Sign Agreement
BlueGnome Signs Agreement with Rubicon Genomics
DaAn Gene to Setup Four Joint Ventures
Gen-Probe and Chiron to Extend Partnership
EnviroLogix Inks Licensing Agreement with Ionian Technologies
HandyLab Extends Partnership with Epoch Biosciences
QIAGEN to Provide Molecular Testing Solutions to Bio-Manguinhos
Nanogen Signs Licensing and Supply Agreement with HandyLab
Blood System Laboratories and Florida Blood Services Establish a Joint Venture
Teva Collaborates with Compugen
QIAGEN Takes-Over Biotage’s Biosystems Unit
QIAGEN Snaps Up Corbett Life Science
Agilent Technologies to Expand API Manufacturing Plant
Polyclone Bioservices to Establish Nucleic Acid Testing Units in India
Pacgen Biopharmaceuticals Signs LoI with Medigen Biotechnology
easyDNA Establishes New DNA Testing Center in India
Apollo Chennai Establishes Nucleic Acid Testing Unit
7.OTHER DEVELOPMENTS
Nanosphere Receives FDA Approval for Respiratory Virus Assay
Roche Diagnostics Obtains FDA Approval for Broader Usage of Nucleic Acid Test
US and European Patent Authorities Award Patents to Gen-Probe for NAT
The National Institute of Allergy and Infectious Diseases Awards $770,000 to Micronics
DaAn Gene Obtains SFDA Approval for Marketing Nucleic Acid Test Kits
Luminex Molecular Diagnostics xTAG Respiratory Viral Panel Approved by FDA
Siemens Healthcare’s Apple iMac OSX Operating System Approved by FDA
Micronics Receives NIH Grant for Developing HIV POC Test
8.FOCUS ON SELECT PLAYERS
Abbott Laboratories, Inc. (US)
Agilent Life Sciences and Chemical Analysis (US)
Applied Biosystems Group (US)
Becton, Dickinson and Company (US)
Bio-Rad Laboratories, Inc. (US)
Cepheid, Inc. (US)
Genomic Health, Inc. (US)
Gen-Probe Inc. (US)
Genzyme Corp. (US)
Genzyme Genetics (US)
Myriad Genetics, Inc. (US)
Novartis AG (Switzerland)
QIAGEN NV (Netherlands)
Roche Diagnostics (US)
Siemens Healthcare Diagnostics, Inc. (US)
Third Wave Technologies, Inc. (US)
9.GLOBAL MARKET PERSPECTIVE
Table 7. World Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 8. World 10-Year Perspective for Nucleic Acid Testing by Geographic Region –Percentage Breakdown of Revenues for US and Rest of World Markets for 2006, 2009 & 2015
III. COMPETITIVE LANDSCAPE
Total Companies Profiled: 46 (including Divisions/Subsidiaries - 49)
Region/CountryPlayers
The United States
Canada
Europe
France
Germany
The United Kingdom
Rest of Europe
Asia-Pacific (Excluding Japan)
Latin America
Middle-East
